+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768212
  • Report
  • April 2019
  • Region: Global
  • 69 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Amgen Inc
  • Archemix Corp
  • Biogen Inc
  • Canadian Apheresis Group
  • CSL Ltd
  • F. Hoffmann-La Roche Ltd
  • MORE
The global clinical trial report- “2019 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease). It presents in-depth analysis of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)

The research work is prepared through extensive and continuous research on Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) patients are identified
  • The report includes panorama of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen Inc
  • Archemix Corp
  • Biogen Inc
  • Canadian Apheresis Group
  • CSL Ltd
  • F. Hoffmann-La Roche Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Region
2.2.2 Average Enrollment of Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Treatment, 2019

3. Region wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials
3.1 Asia Pacific Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Country
3.2 Europe Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Country
3.3 North America Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Country
3.4 Middle East and Africa Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Country
3.5 South and Central America Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Country

4. Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trial Trends
4.1 Start Year wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials
4.2 Phase wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials
4.3 Trial Status wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials
4.4 Trial Type wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials

5. Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment Trends
5.1 Average Enrollment in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials by Year
5.2 Average Enrollment in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials by Phase
5.3 Average Enrollment in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials by Status
5.4 Average Enrollment in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials by Type of Trial

6. Companies Participating in Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials
6.1 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials by Sponsor Type
6.2 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials- Phase 1
7.2 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials- Phase 2
7.3 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials- Phase 3
7.4 Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Figure 7: North America - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Figure 9: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Phase
Figure 10: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Trial Status
Figure 11: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Type
Figure 12: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Sponsor Type
Figure 13: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials by Leading Sponsors
Figure 14: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Phase
Figure 15: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Trial Status
Figure 16: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Type
Figure 17: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)- Average Enrolment by Type of Sponsors
Figure 18: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Table 5: Europe - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Table 7: North America - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Phase
Table 15: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Trial Status
Table 16: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Average Enrollment by Type
Table 17: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)- Average Enrolment by Type of Sponsors
Table 18: Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen Inc
  • Archemix Corp
  • Biogen Inc
  • Canadian Apheresis Group
  • CSL Ltd
  • F. Hoffmann-La Roche Ltd
  • Octapharma AG
  • Pharm-Olam International Ltd
  • Sanofi
  • Shire Plc
Note: Product cover images may vary from those shown
Adroll
adroll